Navigation Links
Mathuram Santosham, M.D., receives 2014 Albert B. Sabin Gold Medal Award

Mathuram Santosham, MD, professor of international health and pediatrics at the Johns Hopkins Bloomberg School of Public Health, received the 2014 Albert Sabin Gold Medal Award from the Sabin Vaccine Institute at an awards ceremony outside Washington, D.C ., last month. The annual award recognizes a member of the public health community for their contributions in the field of vaccinology or a complementary field.

In announcing its award, the Sabin Vaccine Institute noted Dr. Santosham's work with Navajo children, H. Influenza Type b (Hib) vaccine efficacy studies. These findings led to the elimination of Hib in North America and ultimately other western countries. The Institute also praised Dr. Santosham's role in the creation of the Hib Initiative, a project funded by the GAVI-Alliance that promotes Hib vaccines for children in low-income countries. At present all 53 GAVI-eligible countries -- which have a Gross National Income per capita below or equal to $1,570 are using or will soon use the Hib vaccine. GAVI estimates that by 2020 the Hib vaccine will have prevented 7 million deaths.

"I am honored to receive this prestigious award from the Sabin Vaccine Institute, which is also dedicated to reducing needless human suffering by ensuring the availability of safe, low-cost vaccines," said Dr. Santosham, who is also the founder and director of the Center for American Indian Health at the Bloomberg School. "My hope is that scientists, doctors and public health advocates continue to partner with governments and communities around the world to wipe out preventable diseases. Our work against Hib diseases demonstrates what is possible."

Hib disease was the leading cause of bacterial meningitis among U.S. children under 5 years old before the Hib vaccine was introduced, according to the National Institutes of Health. Before the vaccine, about 20,000 U.S. children under age 5 contracted Hib disease, and about 3% to 6% of them died. Globally, the World Health Organization estimates that in 2000 Hib caused between two and three million cases of serious disease and 386,000 deaths in young children.

"We are delighted to honor Dr. Santosham for his advancements against Hib diseases, which caused unnecessary suffering and death prior to his landmark findings and integral policy guidance," said Dr. Peter Hotez, president of the Sabin Vaccine Institute. "His unwavering commitment to scientific discovery and service to marginalized communities in every country mirrors the late Dr. Sabin's core mission and has inspired countless other public health achievements."

The Sabin Vaccine Institute also noted Dr. Santosham's landmark research on oral rehydration solution (ORS) known as Pedialyte which became the standard care for treating diarrheal dehydration and has saved over 50 million lives since 1980.

The Institute presented the Albert B. Sabin Award to Dr. Santosham at a dinner held in conjunction with the National Foundation for Infectious Disease Annual Conference.


Contact: Susan Sperry
Johns Hopkins University Bloomberg School of Public Health

Related medicine news :

1. Molly Carnes, M.D., receives inaugural Linda Joy Pollin Heart Health Leadership Award
2. Francis S. Collins, M.D., Ph.D., to speak at AMP 2014 Annual Meeting
3. BIDMCs Martin Pollak, M.D., elected to National Academy of Sciences
4. Boston Medical Center cardiologist Gary Balady, M.D., receives AHAs Paul Dudley White Award
5. Journal of Spinal Cord Medicine names Dr. Hwang winner of Ernest Bors, M.D., Award
6. IDSA announces new open access journal, names Paul Sax, M.D., editor
7. Harriette M. Scarpero, M.D., & Kate Meriwether, NP, of Associated Urologists of Nashville, LLP, Receive InTone Specialist Certification to Help Women Stop Bladder Leakage
8. UKRO Receives $100,000 Contribution from Kidney Doctor Krishna J. Mohan, M.D., to Fund New Kidney Disease Research Center at the Keck School of Medicine of USC
9. Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association
10. Nancy Andrews, M.D., Ph.D., and Elaine Jaffe, M.D., honored with 2013 Henry M. Stratton Medal
11. Katherine A. High, M.D., to present 2013 American Society of Hematology E. Donnall Thomas Lecture
Post Your Comments:
(Date:11/30/2015)... Viejo, CA (PRWEB) , ... November 30, 2015 , ... ... Cut Pro X . Choose from scrolling web-styled transitions to wipes with blur ... colors, transition direction and more. Seamlessly transition from one clip to the next ...
(Date:11/30/2015)... ... November 30, 2015 , ... Winscribe ... at the Radiological Society of North America (RSNA) 2015 conference. , Leading ... cutting-edge dictation and speech-enabled documentation software, announced their partnership today at RSNA ...
(Date:11/30/2015)... ... November 30, 2015 , ... Several significant coding-related changes are ... likely to include new codes for spine and hip X-rays, paravertebral facet blocks ... of code changes in musculoskeletal, radiology and nervous system sections on an Orthopedic ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... carrier-grade software solutions and services which empower organizations through communication analytics, announced today ... them effectively monitor and manage their service quality. , Proteus® VoIP QMS ...
(Date:11/29/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... November 29, 2015 , ... ... football games, basketball games. Things that as a Mother and Wife would love to ... was no mistake that I just happened to call Dr. Zaidan first. They have ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology: